In human lung cancers, cytoplasmic localization of PRMT5 was found to correlate with high-grade tumors, whereas PRMT5 nuclear localization was more frequent in well-differentiated carcinoid tumors [29]. This evidence concerns the gene PRMT5 and lung carcinoma.